Summary

Terry Noblin completed his Bachelor’s degree in molecular biology at the University of Michigan, where he first discovered his passion for research through the Michigan Research and Discovery Scholars (MRADS) program. During his time at Michigan, he joined Dr. Roger Cone’s lab, working on several impactful projects, including drug discovery for myeloproliferative neoplasms (MPNs) and the development of high-throughput screening protocols. His research in Dr. Cone’s lab led to co-authorship on a publication in Journal of Medicinal Chemistry and provided a strong foundation in molecular and cellular biology.

Currently, Terry is a graduate student at the University of California, San Diego, working jointly in Dr. Gene Yeo’s and Dr. Kevin Corbett’s labs. His research focuses on elucidating the RNA-binding rules of C2H2-type zinc finger proteins, aiming to understand how these proteins interact with RNA at the molecular level. By combining high-throughput methods, structural biology, and computational modeling, he seeks to develop predictive models for RNA-protein interactions that could advance the fields of gene regulation, synthetic biology, and therapeutic development.

Outside of the lab, Terry is passionate about promoting diversity and inclusion in STEM, mentoring students from underrepresented backgrounds, and engaging in science outreach programs. He enjoys lifting weights, exploring the outdoors, and playing Rocket League competitively in his free time. Terry’s commitment to both scientific research and creating inclusive academic spaces reflects his desire to inspire future scientists and contribute meaningfully to the broader scientific community.